Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
This study has been completed.
First Posted: May 10, 2010
Last Update Posted: March 10, 2014
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2013|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||February 6, 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Telen MJ, Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR, Rhee S, Magnani JL, Thackray H. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood. 2015 Apr 23;125(17):2656-64. doi: 10.1182/blood-2014-06-583351. Epub 2015 Mar 2.